AURINIA PHARMACEUTICALS INC's ticker is AUPH and the CUSIP is 05156V102. A total of 200 filers reported holding AURINIA PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 0.86 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $65,364,327 | -19.0% | 8,412,397 | +1.0% | 0.00% | 0.0% |
| Q2 2023 | $80,663,770 | -6.9% | 8,333,034 | +5.4% | 0.00% | -33.3% |
| Q1 2023 | $86,624,715 | +145.4% | 7,903,715 | -3.3% | 0.00% | +200.0% |
| Q4 2022 | $35,296,636 | -39.1% | 8,170,518 | +5.9% | 0.00% | -50.0% |
| Q3 2022 | $58,002,000 | -26.1% | 7,713,055 | -1.3% | 0.00% | -33.3% |
| Q2 2022 | $78,507,000 | +247.0% | 7,811,743 | +327.5% | 0.00% | +200.0% |
| Q1 2022 | $22,624,000 | -45.7% | 1,827,416 | +0.4% | 0.00% | 0.0% |
| Q4 2021 | $41,640,000 | +108.5% | 1,820,739 | +101.7% | 0.00% | 0.0% |
| Q3 2021 | $19,976,000 | +152.3% | 902,663 | +47.7% | 0.00% | – |
| Q2 2021 | $7,919,000 | -44.7% | 610,991 | -44.6% | 0.00% | – |
| Q1 2021 | $14,322,000 | -8.4% | 1,102,988 | -2.4% | 0.00% | – |
| Q4 2020 | $15,632,000 | -13.5% | 1,130,329 | -7.8% | 0.00% | -100.0% |
| Q3 2020 | $18,063,000 | -5.5% | 1,226,284 | +4.3% | 0.00% | 0.0% |
| Q2 2020 | $19,107,000 | +41.4% | 1,175,826 | +26.2% | 0.00% | 0.0% |
| Q1 2020 | $13,516,000 | -23.3% | 931,513 | +7.2% | 0.00% | 0.0% |
| Q4 2019 | $17,612,000 | +261.9% | 869,311 | -4.6% | 0.00% | – |
| Q3 2019 | $4,866,000 | -19.7% | 911,160 | -1.1% | 0.00% | – |
| Q2 2019 | $6,063,000 | +4.4% | 921,425 | +3.1% | 0.00% | – |
| Q1 2019 | $5,807,000 | -11.4% | 893,296 | -7.0% | 0.00% | – |
| Q4 2018 | $6,552,000 | +0.4% | 960,785 | -2.2% | 0.00% | – |
| Q3 2018 | $6,526,000 | +18.2% | 982,885 | +0.3% | 0.00% | – |
| Q2 2018 | $5,520,000 | +1.8% | 980,339 | -6.2% | 0.00% | – |
| Q1 2018 | $5,424,000 | +66.3% | 1,045,121 | +45.2% | 0.00% | – |
| Q4 2017 | $3,261,000 | – | 719,713 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Berry Street Capital Management LLP | 1,987,500 | $24,605,000 | 2.79% |
| NEA Management Company, LLC | 3,969,834 | $49,146,000 | 1.42% |
| IRONWOOD INVESTMENT MANAGEMENT LLC | 133,117 | $1,648,000 | 0.90% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 435,000 | $3,955,000 | 0.89% |
| ACT CAPITAL MANAGEMENT, LLC | 67,500 | $836,000 | 0.88% |
| Artal Group S.A. | 1,000,000 | $12,380,000 | 0.52% |
| CTC Capital Management, LLC | 12,800 | $158,000 | 0.42% |
| KESTRA PRIVATE WEALTH SERVICES, LLC | 581,910 | $7,204,000 | 0.36% |
| Affinity Asset Advisors, LLC | 175,000 | $2,167,000 | 0.35% |
| Bellevue Group AG | 2,405,825 | $29,784,000 | 0.35% |